Literature DB >> 8270686

Efficacy of intramammary antibiotic therapy for treatment of clinical mastitis caused by environmental pathogens.

W M Guterbock1, A L Van Eenennaam, R J Anderson, I A Gardner, J S Cullor, C A Holmberg.   

Abstract

For three California dairy herds with bulk tank SCC < 200,000/ml, twice daily milking, and no mastitis vaccine, 254 quarters with mild clinical mastitis were randomly assigned to three groups. Group A (n = 74) was treated with 62.5 mg of intramammary amoxicillin every 12 h for three milkings. Group C (n = 75) was treated with 200 mg of intramammary cephapirin every 12 h for two milkings. Group O (n = 105) was treated with 100 units of intramuscular oxytocin every 12 h for two or three milkings. Aseptic pretreatment quarter samples revealed 94 (37%) coliforms, 65 (26%) environmental streptococci, 34 (13%) other bacteria, and 61 (24%) with no isolate on bovine blood agar plates. Contagious pathogens were not isolated. Clinical cure (return of quarter and milk to normal) and bacterial cure (absence of primary pathogen isolated pretreatment) were assessed at milking 8 and d 20 after initial treatment. No difference existed in clinical (67.6, 67.7, or 66.7%) or bacterial (43.9, 55.0 or 49.1%) cure rate among groups. Clinical cure rates did not differ when quarters were grouped by etiology, but clinical cure rates for quarters with pathogens other than streptococci or coliforms were lower in group O.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8270686     DOI: 10.3168/jds.S0022-0302(93)77682-1

Source DB:  PubMed          Journal:  J Dairy Sci        ISSN: 0022-0302            Impact factor:   4.034


  6 in total

1.  Design and characterisation of a polyethylene oxide matrix with the potential use as a teat insert for prevention/treatment of bovine mastitis.

Authors:  Sushila Bhattarai; Raid G Alany; Craig R Bunt; Hamdy Abdelkader; Michael J Rathbone
Journal:  AAPS J       Date:  2014-10-16       Impact factor: 4.009

Review 2.  TRIENNIAL LACTATION SYMPOSIUM/BOLFA: Pathogen-specific immune response and changes in the blood-milk barrier of the bovine mammary gland.

Authors:  R M Bruckmaier; O Wellnitz
Journal:  J Anim Sci       Date:  2017-12       Impact factor: 3.159

3.  Efficacy of a botanical preparation for the intramammary treatment of clinical mastitis on an organic dairy farm.

Authors:  Pablo Pinedo; Hubert Karreman; Hans Bothe; Juan Velez; Carlos Risco
Journal:  Can Vet J       Date:  2013-05       Impact factor: 1.008

4.  Withdrawal of Amoxicillin and Penicillin G Procaine from Milk after Intramammary Administration in Dairy Cows with Mastitis.

Authors:  Artur Burmańczuk; Grabowski Tomasz; Małgorzata Gbylik-Sikorska; Anna Gajda; Cezary Kowalski
Journal:  J Vet Res       Date:  2017-04-04       Impact factor: 1.744

5.  Bacillus amyloliquefaciens-9 Reduces Somatic Cell Count and Modifies Fecal Microbiota in Lactating Goats.

Authors:  Yongtao Li; Nannan Jiang; Wenying Zhang; Zhengbing Lv; Jianxin Liu; Hengbo Shi
Journal:  Mar Drugs       Date:  2021-07-21       Impact factor: 5.118

6.  Comparative effectiveness of individualised homeopathy and antibiotics in the treatment of bovine clinical mastitis: randomised controlled trial.

Authors:  Diana Keller; Albert Sundrum
Journal:  Vet Rec       Date:  2018-01-26       Impact factor: 2.695

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.